Advanced Medical Diagnostics ($0.115) Confirms Brazilian Order
TRPL - HIV (1&2) Rapid Test Kits are priced to sell for US$4.00 each. This represents a bottom line profit in excess of $1.00 per kit for AMD," said Michael Gilbert, President of AMD. Gilbert also commented, "Once product testing, certification and registration, as required by the Brazilian Health Ministry is completed, we anticipate orders between 1,000,000 and 5,000,000 units of our Rapid Test Kits from Brazil alone. In dollar terms, such orders could represent approximately US$4,000,000 to US$20,000,000 in revenue. Profit to the company would be significant."
today just an intial order until its approved in Brazil then the follow on contract is anticioated to be between $4 million & $20 million US!
Still awaiting news from West African Nations.....as per one of their last PR (9 Sept 04).....orders are imminent...
I like this part of todays PR.....TRPL has huge revenue potnetial...
"Once product testing, certification and registration, as required by the Brazilian Health Ministry is completed, we anticipate orders between 1,000,000 and 5,000,000 units of our Rapid Test Kits from Brazil alone. In dollar terms, such orders could represent approximately US$4,000,000 to US$20,000,000 in revenue. Profit to the company would be significant." http://biz.yahoo.com/pz/040916/63946.html
IP: Logged |
posted
insiders recently bought about 8.5 million shares on the open market between .10 & .32!! see item 5 c! With the huge potential I see why they are so keen on the company!
Item 5. Interest in Securities of the Issuer
(a) The aggregate number of common shares of the Company beneficially owned by Mr. and Mrs. Waltzer is 8,439,000, of which 5,984,000 are held in the name of Kevin Waltzer and 2,455,000 are held in the name of Lisa Waltzer. Based upon a review of the Company's Form 10-QSB filed with the US Securities and Exchange Commission on May 17, 2004, the aggregate holdings of Mr. and Mrs. Walter represent approximately 21.3% of the issued and outstanding common shares of the Company. The shares held in the name of Kevin Waltzer represent approximately 15.1% of the Company's issued and outstanding common shares and the shares held in the name of Lisa Waltzer represent approximately 6.2% of the Company's issued and outstanding common shares.
(b) Kevin Waltzer has sole voting power and sole dispositive power with respect to 5,984,000 common shares held in the name of Kevin Waltzer and Lisa Waltzer and Kevin Waltzer have shares voting power and shared dispositive power with respect to 2,455,000 common shares held in the name of Lisa Waltzer.
(c) The acquisition of the Company's common shares by Kevin Waltzer was effected in 59 open market transactions from May 28, 2004 through June 15, 2004 at prices ranging from $.102 per share through $.325 per share. The acquisition of the Company's common shares by Lisa Waltzer was effected in 35 open market transactions from May 26, 2004 through June 10, 2004 at prices ranging from $.09 per share through $.245 per share.